LAVA Therapeutics Statistics
Total Valuation
LVTX has a market cap or net worth of $42.75 million. The enterprise value is -$13.42 million.
Important Dates
The next estimated earnings date is Tuesday, December 9, 2025, before market open.
| Earnings Date | Dec 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LVTX has 26.31 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 26.31M |
| Shares Outstanding | 26.31M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 12.00% |
| Float | 17.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.75 |
| Forward PS | n/a |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.78
| Current Ratio | 10.78 |
| Quick Ratio | 10.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -67.64 |
Financial Efficiency
Return on equity (ROE) is -90.19% and return on invested capital (ROIC) is -47.19%.
| Return on Equity (ROE) | -90.19% |
| Return on Assets (ROA) | -21.30% |
| Return on Invested Capital (ROIC) | -47.19% |
| Return on Capital Employed (ROCE) | -47.40% |
| Revenue Per Employee | $146,765 |
| Profits Per Employee | -$833,059 |
| Employee Count | 34 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LVTX has paid $773,000 in taxes.
| Income Tax | 773,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.36% in the last 52 weeks. The beta is 0.49, so LVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -15.36% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 59.87 |
| Average Volume (20 Days) | 491,402 |
Short Selling Information
The latest short interest is 179,838, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 179,838 |
| Short Previous Month | 116,555 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 1.03% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
In the last 12 months, LVTX had revenue of $4.99 million and -$28.32 million in losses. Loss per share was -$1.05.
| Revenue | 4.99M |
| Gross Profit | -19.56M |
| Operating Income | -26.04M |
| Pretax Income | -27.55M |
| Net Income | -28.32M |
| EBITDA | -25.72M |
| EBIT | -26.04M |
| Loss Per Share | -$1.05 |
Full Income StatementBalance Sheet
The company has $56.17 million in cash and n/a in debt, giving a net cash position of $56.17 million or $2.14 per share.
| Cash & Cash Equivalents | 56.17M |
| Total Debt | n/a |
| Net Cash | 56.17M |
| Net Cash Per Share | $2.14 |
| Equity (Book Value) | 19.94M |
| Book Value Per Share | 0.76 |
| Working Capital | 54.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$35.88 million and capital expenditures -$23,000, giving a free cash flow of -$35.90 million.
| Operating Cash Flow | -35.88M |
| Capital Expenditures | -23,000 |
| Free Cash Flow | -35.90M |
| FCF Per Share | -$1.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -521.84% |
| Pretax Margin | -552.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.42% |
| Shareholder Yield | 0.42% |
| Earnings Yield | -66.26% |
| FCF Yield | -83.99% |
Analyst Forecast
The average price target for LVTX is $1.58, which is -2.77% lower than the current price. The consensus rating is "Hold".
| Price Target | $1.58 |
| Price Target Difference | -2.77% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -22.90% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LVTX has an Altman Z-Score of -4.01 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.01 |
| Piotroski F-Score | 1 |
